{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:40:10Z","timestamp":1765827610904},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T00:00:00Z","timestamp":1505520000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Swiss Federal Comission for Technology","award":["CTI grant number 18712.1 PFES-ES"],"award-info":[{"award-number":["CTI grant number 18712.1 PFES-ES"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11239-017-1554-5","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T04:29:15Z","timestamp":1505536155000},"page":"494-506","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives"],"prefix":"10.1007","volume":"44","author":[{"given":"Zanfina","family":"Ademi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Simone","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Van Stiphout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6elle","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goranka","family":"Tanackovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schwenkglenks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,16]]},"reference":[{"issue":"3","key":"1554_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beha.2012.06.007","volume":"25","author":"SZ Goldhaber","year":"2012","unstructured":"Goldhaber SZ (2012) Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol 25(3):235 \u2013 42","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"1554_CR2","first-page":"452","volume":"2005","author":"M Cushman","year":"2005","unstructured":"Cushman M (2005) Inherited risk factors for venous thrombosis. ASH Educ Progr Book 2005(1):452\u2013457","journal-title":"ASH Educ Progr Book"},{"issue":"16","key":"1554_CR3","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","volume":"344","author":"U Seligsohn","year":"2001","unstructured":"Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous thrombosis. N Engl J Med 344(16):1222\u20131231","journal-title":"N Engl J Med"},{"issue":"1","key":"1554_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","volume":"27","author":"S Christin-Maitre","year":"2013","unstructured":"Christin-Maitre S (2013) History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab 27(1):3\u201312","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"1554_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","volume":"94","author":"O Wu","year":"2005","unstructured":"Wu O, Robertson L, Langhorne P et al (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Thromb Haemost 94(1):17\u201325","journal-title":"Thromb Haemost"},{"key":"1554_CR6","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"O Lidegaard","year":"2011","unstructured":"Lidegaard O, Nielsen LH, Skovlund CW et al (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-2009. BMJ 343:d6423","journal-title":"BMJ"},{"key":"1554_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010813.pub2","author":"M de Bastos","year":"2014","unstructured":"de Bastos M, Stegeman Bernardine H, Rosendaal Frits R et al (2014) Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. doi: 10.1002\/14651858.CD010813.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1554_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010813","author":"M de Bastos","year":"2014","unstructured":"de Bastos M, Stegeman BH, Rosendaal FR et al (2014) Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. doi: 10.1002\/14651858.CD010813","journal-title":"Cochrane Database Syst Rev"},{"key":"1554_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1472-6963-6-67","volume":"6","author":"RJ McKinlay","year":"2006","unstructured":"McKinlay RJ, Wilczynski NL, Haynes RB (2006) Optimal search strategies for detecting cost and economic studies in EMBASE. BMC Health Serv Res 6:67","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"1554_CR10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1503\/cmaj.1040512","volume":"171","author":"NL Wilczynski","year":"2004","unstructured":"Wilczynski NL, Haynes RB, Lavis JN et al (2004) Optimal search strategies for detecting health services research studies in MEDLINE. CMAJ 171(10):1179\u20131185","journal-title":"CMAJ"},{"issue":"5","key":"1554_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00005650-200205000-00004","volume":"40","author":"F Sassi","year":"2002","unstructured":"Sassi F, Archard L, McDaid D (2002) Searching literature databases for health care economic evaluations: how systematic can we afford to be? Med Care 40(5):387\u2013394","journal-title":"Med Care"},{"key":"1554_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. doi: 10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"1554_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1049","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S et al (2013) Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ. doi: 10.1136\/bmj.f1049","journal-title":"BMJ"},{"issue":"5","key":"1554_CR14","first-page":"317","volume":"91","author":"T Szucs","year":"1983","unstructured":"Szucs T, Osterkorn D, Schramm W (1983) Public health economic evaluation of screening for APC resistance (Leiden mutation) in new oral contraceptive users. Medizinische Klinik 91(5):317\u2013319","journal-title":"Medizinische Klinik"},{"issue":"3","key":"1554_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1160\/TH08-03-0149","volume":"100","author":"KJ Smith","year":"2008","unstructured":"Smith KJ, Monsef BS, Ragni MV (2008) Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis. Thromb Haemost 100(3):447\u2013452","journal-title":"Thromb Haemost"},{"issue":"1","key":"1554_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","volume":"131","author":"O Wu","year":"2005","unstructured":"Wu O, Robertson L, Twaddle S et al (2005) Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol 131(1):80\u201390","journal-title":"Br J Haematol"},{"issue":"6","key":"1554_CR17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jval.2013.05.003","volume":"16","author":"A Compagni","year":"2013","unstructured":"Compagni A, Melegaro A, Tarricone R (2013) Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system. Value Health 16(6):909\u2013921","journal-title":"Value Health"},{"issue":"9321","key":"1554_CR18","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(02)08740-8","volume":"359","author":"P Clark","year":"2002","unstructured":"Clark P, Twaddle S, Walker ID et al (2002) Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women. The Lancet 359(9321):1919\u20131920","journal-title":"The Lancet"},{"issue":"4","key":"1554_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.annemergmed.2010.03.029","volume":"56","author":"RS Duriseti","year":"2010","unstructured":"Duriseti RS, Brandeau ML (2010) Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms. Ann Emerg Med 56(4):321\u2013332","journal-title":"Ann Emerg Med"},{"issue":"26","key":"1554_CR20","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJM199406303302605","volume":"330","author":"JJ O\u2019Meara","year":"1994","unstructured":"O\u2019Meara JJ, McNutt RA, Evans AT et al (1994) A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 330(26):1864\u20131869","journal-title":"N Engl J Med"},{"issue":"1","key":"1554_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1477-7525-8-49","volume":"8","author":"DA Cadilhac","year":"2010","unstructured":"Cadilhac DA, Dewey HM, Vos T et al (2010) The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS). Health Qual Life Outcomes 8(1):49","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1554_CR22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/027298902400448902","volume":"22","author":"P Clarke","year":"2002","unstructured":"Clarke P, Gray A, Holman R (2002) Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Mak 22(4):340\u2013349","journal-title":"Med Decis Mak"},{"issue":"1","key":"1554_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1477-7525-6-65","volume":"6","author":"SP McKenna","year":"2008","unstructured":"McKenna SP, Ratcliffe J, Meads DM et al (2008) Development and validation of a preference based measure derived from the Cambridge pulmonary hypertension outcome review (CAMPHOR) for use in cost utility analyses. Health Qual Life Outcomes 6(1):65","journal-title":"Health Qual Life Outcomes"},{"key":"1554_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2890","author":"\u00d8 Lidegaard","year":"2009","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Svendsen AL et al (2009) Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. doi: 10.1136\/bmj.b2890","journal-title":"BMJ"},{"key":"1554_CR25","doi-asserted-by":"crossref","unstructured":"Aujesky D, Smith KJ, Roberts MS. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event. Am J Med 118(6):625\u2013635","DOI":"10.1016\/j.amjmed.2005.02.018"},{"issue":"4","key":"1554_CR26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1160\/TH07-12-0720","volume":"99","author":"F Couturaud","year":"2008","unstructured":"Couturaud F, Leroyer C, Mottier D (2008) Risk factors and clinical presentation of venous thromboembolism according to the age of relatives of patients with factor V Leiden. Thromb Haemost 99(4):793\u2013794","journal-title":"Thromb Haemost"},{"issue":"5","key":"1554_CR27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7326\/0003-4819-135-5-200109040-00008","volume":"135","author":"S Middeldorp","year":"2001","unstructured":"Middeldorp S, Meinardi JR, Koopman MM et al (2001) A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 135(5):322\u2013327","journal-title":"Ann Intern Med"},{"issue":"8935","key":"1554_CR28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","volume":"344","author":"JP Vandenbroucke","year":"1994","unstructured":"Vandenbroucke JP, Koster T, Briet E et al (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. The Lancet 344(8935):1453\u20131457","journal-title":"The Lancet"},{"issue":"1","key":"1554_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1160\/TH15-01-0045","volume":"115","author":"P Suchon","year":"2016","unstructured":"Suchon P, Al Frouh F, Henneuse A et al (2016) Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl genetic risk monitoring (PILGRIM) study. Thromb Haemost 115(1):135\u2013142","journal-title":"Thromb Haemost"},{"issue":"2","key":"1554_CR30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0033-0620(03)00085-9","volume":"46","author":"LJ Shaw","year":"2003","unstructured":"Shaw LJ, Raggi P, Berman DS et al (2003) Cost effectiveness of screening for cardiovascular disease with measures of coronary calcium. Prog Cardiovasc Dis 46(2):171\u2013184","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"1554_CR31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hec.1148","volume":"15","author":"A Brennan","year":"2006","unstructured":"Brennan A, Chick SE, Davies R (2006) A taxonomy of model structures for economic evaluation of health technologies. Health Econ 15(12):1295\u20131310","journal-title":"Health Econ"},{"issue":"9","key":"1554_CR32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/JOM.0000000000000208","volume":"56","author":"RL Page","year":"2014","unstructured":"Page RL,, Ghushchyan V, Gifford B et al (2014) Hidden costs associated with venous thromboembolism: impact of lost productivity on employers and employees. J Occup Environ Med 56(9):979\u2013985","journal-title":"J Occup Environ Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-017-1554-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T15:17:57Z","timestamp":1570115877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-017-1554-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,16]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1007\/s11239-017-1554-5","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,16]]}}}